ARS Pharmaceuticals, Inc. Quarterly Operating Lease, Payments in USD from Q1 2020 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
ARS Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2020 to Q3 2022.
  • ARS Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending September 30, 2022 was $458K, a 8.22% decline year-over-year.
  • ARS Pharmaceuticals, Inc. Operating Lease, Payments for the twelve months ending September 30, 2022 was $1.99M, a 14.1% increase year-over-year.
  • ARS Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $1.84M, a 15.7% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $1.99M $458K -$41K -8.22% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $2.03M $503K +$90K +21.8% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $1.94M $518K +$97K +23% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $1.84M $508K +$99K +24.2% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-31
Q3 2021 $1.74M $499K +$103K +26% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $1.64M $413K +$24K +6.17% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $1.62M $421K +$24K +6.05% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $1.59M $409K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $396K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $389K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $397K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.